-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces It Is Investigating Claims Against Caribou Biosciences, Inc. and Encourages Investors With Losses to Contact the Firm
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces It Is Investigating Claims Against Caribou Biosciences, Inc. and Encourages Investors With Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Caribou Biosciences, Inc. ("Caribou" or "the Company") (NASDAQ: CRBU) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Caribou announced on December 12, 2022, "report[ing] new 12-month clinical data from cohort 1 in the ongoing ANTLER Phase 1 trial, which show long-term durability following a single infusion of CB-010 at the initial dose level 1 (40x106 CAR-T cells)." According to the Company, "3 of 6 patients maintained a durable CR [complete response] at 6 months," and "2 of 6 patients maintain a long-term CR at the 12 month scan and remain on the trial." Based on this news, shares of Caribou fell by more than 9% on the same day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at , or by email at bschall@schallfirm.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
To view the source version of this press release, please visit
Los Angeles, California--(Newsfile Corp. - December 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Caribou Biosciences, Inc. ("Caribou" or "the Company") (NASDAQ: CRBU) for violations of the securities laws.
加利福尼亚州洛杉矶--(Newsfile Corp.-2022年12月26日)-全国性股东权利诉讼公司Schall律师事务所宣布,它正在代表Cariou生物科学公司(“Cariou”或“公司”)(纳斯达克:CRBU)的投资者调查违反证券法的索赔。
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Caribou announced on December 12, 2022, "report[ing] new 12-month clinical data from cohort 1 in the ongoing ANTLER Phase 1 trial, which show long-term durability following a single infusion of CB-010 at the initial dose level 1 (40x106 CAR-T cells)." According to the Company, "3 of 6 patients maintained a durable CR [complete response] at 6 months," and "2 of 6 patients maintain a long-term CR at the 12 month scan and remain on the trial." Based on this news, shares of Caribou fell by more than 9% on the same day.
调查的重点是该公司是否发布了虚假和/或误导性声明和/或没有披露与投资者相关的信息。驯鹿于2022年12月12日宣布[英]在正在进行的鹿角第一阶段试验中,来自队列1的新的12个月临床数据显示,在以初始剂量水平1(40x106 CAR-T细胞)单次输注CB-010后,这些数据显示出长期的持久性。根据该公司的说法,6名患者中有3名保持了持久的CR[完整的回应]在6个月后,6名患者中有2名在12个月的扫描中保持长期CR,并继续接受试验。基于这一消息,Cariou的股价在同一天下跌了9%以上。
If you are a shareholder who suffered a loss, click here to participate.
如果您是蒙受损失的股东,请单击此处参与。
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at , or by email at bschall@schallfirm.com.
我们还鼓励您联系Schall律师事务所的Brian Schall,1880世纪公园东区,404Suite404,洛杉矶,CA 90067,电话:310301-3335,讨论您的免费权利。您也可以通过公司的网站或电子邮件bschall@schallffer.com联系我们。
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
本案中的课程尚未获得认证,在获得认证之前,您不会由律师代表。如果你选择不采取行动,你可以保持缺席班级成员的身份。
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
Schall律师事务所代表世界各地的投资者,专门处理证券集体诉讼和股东权利诉讼。
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
根据适用的法律和道德规则,本新闻稿在某些司法管辖区可能被视为律师广告。
CONTACT:
联系方式:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
沙尔律师事务所
布莱恩·舒尔,Esq.
310-301-3335
邮箱:Info@schallFirm.com
To view the source version of this press release, please visit
要查看本新闻稿的源版本,请访问
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧